Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SPECTROstar Nano - Instantly capture a full absorbance spectrum for microplates, low volumes, and cuvettes

Product Description
spectrostar-nano.gif

Experience the future of microplate reader technology today with the SPECTROstar Nano. Using an ultrafast CCD-based spectrometer, it can capture a full UV-Vis absorbance spectrum from 220 to 1000 nm in 1, 2, 5, or 10 nm increments in less than 1 second per well. Monochromators cannot match the speed or resolution of a spectrometer. In addition, it can measure a full spectrum in all microplate formats from 6- to 1536-wells, as well as low volumes (2uL) in BMG LABTECH’s LVis microplate. Full spectra of individual samples can also be assessed by using the integrated cuvette port. This port accommodates standard, micro, and ultra-low volume cuvettes for measurements of 1uL.

The SPECTROstar Nano makes absorbance measurements easy with app-style, one-click button operation and predefined protocols for the most common absorbance assays such as ELISAs, DNA, RNA, protein (Bradford, BCA, Lowry), cell growth, beta-galactosidase, MTT toxicity, enzyme kinetics, and many more.

Some of the outstanding features include:

• Ultra-fast UV/Vis spectrometer
• Spectrum 220 to 1000 nm in <1 sec/well
• Microplate formats up to 1536 wells
• Cuvette port for standard, micro and ultra-low volume cuvettes
• Low volumes down to 2 µL
• Multimode shaking and incubation
• Well scanning, kinetic and endpoint measurements
• Gas vent for atmospheric sensitive samples
• Powerful MARS Data Analysis Software
• Robot compatible
Product SPECTROstar Nano - Instantly capture a full absorbance spectrum for microplates, low volumes, and cuvettes
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!